Escitalopram and citalopram in outpatients suffering from severe major depressive disorder: A prospective, observational, eight-week study

被引：0
|
作者：
Lancon, C
Sapin, C
Note, I
Farisse, J
机构：
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2004年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S349 / S349
页数：1
相关论文
共 50 条
  • [21] Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder (vol 21, pg 131, 2005)
    Moore, N
    Verdoux, H
    Fantino, B
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2005, 20 (04) : 242 - 242
  • [22] Efficacy and Safety of Escitalopram Oral Drops to Treat Major Depressive Disorder and Generalized Anxiety Disorder in Adolescent, Adult and Geriatric Patients: A Prospective Multicenter Observational Study in Pakistan
    Afridi, Muhammad Iqbal
    Dogar, Imtiaz Ahmad
    Nizami, Asad T.
    Aslam, Rubina
    Mustafa, Ali Burhan
    Muhammad, Sharib Syed
    Maheshwary, Neeta
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (01)
  • [23] Preliminary study of emotional blunting in patients suffering from major depressive disorder
    Iglesias-Gonzalez, M.
    Robles-Martinez, M.
    Cuevas-Esteban, J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S56 - S56
  • [24] Cross-sectional evaluation of health state utility in Swedish outpatients suffering from major depressive disorder
    Eriksson, T.
    [J]. VALUE IN HEALTH, 2006, 9 (06) : A323 - A323
  • [25] Eight-week antidepressant treatment changes intrinsic functional brain topology in first-episode drug-naive patients with major depressive disorder
    Dai, You -Ran
    Wu, Yan-Kun
    Chen, Xiao
    Zeng, Ya-Wei
    Li, Ke
    Li, Ji-Tao
    Su, Yun-Ai
    Zhu, Lin -Lin
    Yan, Chao-Gan
    Si, Tian -Mei
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2023, 329 : 225 - 234
  • [26] Effect of citalopram versus escitalopram on quality of life in the treatment of the acute phase of major depressive disorder: a comparative, open-label study
    Aydemir, Omer
    Ergun, Hakan
    Kesebir, Sermin
    Soygur, Haldun
    Tulunay, Cankat
    [J]. KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 21 (03): : 210 - 218
  • [27] A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder
    Colonna, L
    Andersen, HF
    Reines, EH
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (10) : 1659 - 1668
  • [28] Impact of gender, depression severity and type of depressive episode on efficacy and safety of escitalopram: an observational study on major depressive disorder patients in southern India
    Mandal, Tatiyana
    Bairy, Laxminarayana Kurady
    Sharma, Podila Satya Venkata Narasimha
    Valaparla, Vijaya Lakshmi
    [J]. EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2021, 57 (01):
  • [29] Impact of gender, depression severity and type of depressive episode on efficacy and safety of escitalopram: an observational study on major depressive disorder patients in southern India
    Tatiyana Mandal
    Laxminarayana Kurady Bairy
    Podila Satya Venkata Narasimha Sharma
    Vijaya Lakshmi Valaparla
    [J]. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 57
  • [30] Vortioxetine vs escitalopram regarding cognitive and functional recovery in the Ukrainian cohort of patients with major depressive disorder: An 8-week study
    Troian, O.
    Levada, O.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S32 - S32
12345